Clinical Trial Update: SHR-A1921 Combined With Adebrelimab in the Treatment of Advanced NSCLC Who Failed the Previous Standard First-line Treatment [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating SHR-A1921 combined with adebrelimab for advanced non-small cell lung cancer in patients who failed prior first-line therapy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)
• SHR-A1921

Snippet

Sponsor: Shanghai Pulmonary Hospital, Shanghai, China | Conditions: NSCLC | Phase 2 | Status: NOT_YET_RECRUITING